patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Autom8ion..on the contrary, imo, the reverse split and subsequent NASD listing
has protected shareholders, while attracting other types of shareholders going forward. I am very pleased that PSTI has accomplished this transition so quickly!
Share
New Message
Please login to post a reply